Advertisement
Organisation › Details
Amgen (Group)
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, psoriasis, psoriatic arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. *
Start | 1980-01-01 established | |
Industry | BIOTECH | |
Region | Thousand Oaks, CA | |
Country | United States (USA) | |
Street | One Amgen Center Drive | |
City | 91320-1799 Thousand Oaks, CA | |
Tel | +1-805-447-1000 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 14,771,000,000 (revenues, total, consolidated (2007) 2007-12-31) | |
Profit | 3,166,000,000 (2007-12-31) | |
Cash | 7,151,000,000 (2007-12-31) | |
* Document for »About Section«: | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Amgen (Group)
- [1] Precision BioSciences, Inc.. (2/13/24). "Press Release: Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations". Durham, NC....
- [2] Synaffix B.V.. (1/5/23). "Press Release: Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs". Amsterdam....
- [3] Amgen Inc.. (12/13/22). "Press Release: Blincyto (blinatumomab) Added to Consolidation Chemotherapy Significantly Improves Survival in Adult Patients with Measurable Residual Disease-negative B-Lieage Acute Lymphoblastic Leukemia (B-ALL)". Thousand Oaks,...
- [4] Amgen Inc.. (12/12/22). "Press Release: Rule 2.7 Announcement. Amgen Inc to Acquire Horizon Therapeutics plc". Thousand Oaks, CA....
- [5] Amgen Inc.. (8/4/22). "Press Release: Amgen to Acquire ChemoCentryx for $4 Billion in Cash". Thousand Oaks, CA & San Carlos, CA....
- [6] Vaccentis AG. (7/12/22). "Press Release: Vaccentis Appoints Martin Munte as CEO and Strengthens Board". Zurich....
- [7] Nordic Nanovector ASA. (9/14/21). "Press Release: Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer". Oslo....
- [8] Five Prime Therapeutics Inc.. (3/4/21). "Press Release: Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash". Thousand Oaks, CA & South San Francisco, CA....
- [9] Vigil Neuroscience, Inc.. (12/8/20). "Press Release: Vigil Neuroscience Launches with $50 Million in Financing to Develop Microglia-based Therapeutics for Neurodegenerative Diseases". Cambridge, MA....
- [10] NewAmsterdam Pharma B.V.. (8/25/20). "Press Release: NewAmsterdam Pharma Acquires Obicetrapib from Amgen". Naarden....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top